On 21 March, Bryn Mawr Bank Corp. (NASDAQ:BMTC) shares remains unchanged and was closed at $25.69. BMTC EPS growth in last 5 year was 2.00%. Bryn Mawr Bank Corp. (NASDAQ:BMTC) year to date (YTD) performance is -10.55%.
Bryn Mawr Bank Corp. (NASDAQ:BMTC) said that, direction will announce earnings reports 2016 05 05.
bluebird bio, Inc. (NASDAQ:BLUE) shares decreased -1.39% in last trading session and ended the day at $44.02. BLUE has a return on assets of -18.80%. bluebird bio, Inc. (NASDAQ:BLUE) quarterly performance is -29.00%.
bluebird bio, Inc. (NASDAQ:BLUE) said that, Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Investor Day on Tuesday, March 22, 2016, at 1:55 p.m. ET at the Metropolitan Club in New York City.
Ensco plc (NYSE:ESV) caters to the Basic Materials space. It has a net profit margin of -39.30% and weekly performance is 3.38%. On the last day of trading company shares ended up at $11.33. Ensco plc (NYSE:ESV) distance from 50-day simple moving average (SMA50) is 15.06%.
Ensco plc (NYSE:ESV) announced that it has commenced cash tender offers (collectively, the “Tender Offers,” and each offer to purchase a series of notes individually, a “Tender Offer”) to purchase up to $750,000,000 aggregate purchase price, exclusive of accrued interest (the “Aggregate Maximum Purchase Amount”), of the outstanding notes of Ensco and its wholly owned subsidiary Pride International, Inc. (“Pride”) set forth in the table below (collectively, the “Notes”).
Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) shares moved up 5.89% in last trading session and ended the day at $8.81. AQXP has a return on assets of -29.60%. Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) quarterly performance is -28.49%.
On 14 March, Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) reported General and administrative expenses for 2015 increased to $5.5 million compared to $4.3 million for 2014. This increase was primarily due to higher personnel related costs, legal and consulting expenses.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) caters to the Healthcare space. Its weekly performance is 19.69%. On the last day of trading company shares ended up at $3.10. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) distance from 50-day simple moving average (SMA50) is 21.39%.
On 21 March, HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) announced that it has entered into a long-term agreement with Thermo Fisher Scientific under which HTG will have the right to develop a number of in-vitro diagnostic (IVD) tests for use with Thermo Fisher’s next-generation sequencing Ion PGM Dx System.
Leave a Reply